Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Jonsson Comprehensive Cancer Center Clinical Trials Info presented on Clinical Trials Search is not designed to be a substitute for proven health advice, calls or professional assistance by using a real physician. We are not mDs. Always confer with your doctor on Jonsson Comprehensive Cancer Center clinical studies. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Jonsson Comprehensive Cancer Center Clinical research trials and Jonsson Comprehensive Cancer Center health trials occur in a lot of of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectivity of new does drugs. The function of the studies / undertakings is to figure out specific human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations like Jonsson Comprehensive Cancer Center to find cures for all forms of conditions. Jonsson Comprehensive Cancer Center Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the general public. Many times the participants recieve professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Jonsson Comprehensive Cancer Center clinical trial. Participants oftentimes get the most expert healthcare possible for their condition. Risks are a reality, nevertheless, and may include extra or frequent doctor calls, healthcare risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with exacting guidelines to protect clinical trials subjects.

Home > "J" Clinical Trials Sponsors > Jonsson Comprehensive Cancer Center Clinical Trials

Jonsson Comprehensive Cancer Center Clinical Trials


AG-858 and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Were Previously Treated With Imatinib Mesylate
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Bevacizumab in Treating Patients With Metastatic Breast or Colorectal Cancer Who Received Bevacizumab on a Phase II or Phase III Clinical Trial
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Biological Therapy in Treating Patients With Prostate Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

CC-5013 in Treating Patients With Advanced Multiple Myeloma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

CC-5013 in Treating Patients With Progressive or Relapsed Metastatic Melanoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

CP-724,714 in Treating Patients With Metastatic Breast Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Cryosurgery in Treating Women With Breast Lesions
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Dexmethylphenidate in Treating Patients With Fatigue and Behavior Change After Chemotherapy
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Epothilone B in Treating Patients With Advanced Kidney Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Gemcitabine With or Without cBR96-Doxorubicin Immunoconjugate (SGN-15) in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Gene Therapy Combined With Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer That Cannot Be Surgically Removed
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

LY317615 in Treating Patients With Relapsed or Refractory Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibodies in Treating Patients with Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Plus Carboplatin and Paclitaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center



Jonsson Comprehensive Cancer Center Clinical Trials

Modify your Search

Other "J" Clinical Trials Sponsors:

Jacobus Pharmaceutical
James P. Wilmot Cancer Center
Janssen Pharmaceutica
Jewish Hospital
Johns Hopkins Oncology Center
Johnson & Johnson Pharmaceutical Research And Development, L.l.c.
Johnson & Johnson Research Pty Limited
Jonsson Comprehensive Cancer Center